![Consensus document on treatment of type 2 diabetes in patients with chronic kidney disease* | Nefrología Consensus document on treatment of type 2 diabetes in patients with chronic kidney disease* | Nefrología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/X2013251414053670:12369_16025_54391_en_f312369_06.jpg?idApp=UINPBA000064)
Consensus document on treatment of type 2 diabetes in patients with chronic kidney disease* | Nefrología
![Kidney and Dialysis | Free Full-Text | GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease Kidney and Dialysis | Free Full-Text | GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease](https://pub.mdpi-res.com/kidneydial/kidneydial-02-00034/article_deploy/html/images/kidneydial-02-00034-g001.png?1657016264)
Kidney and Dialysis | Free Full-Text | GLP-1 Receptor Agonists in the Treatment of Patients with Type 2 Diabetes and Chronic Kidney Disease
![Pharmacological Management of Glycaemia in People with Type 2 Diabetes and Renal Impairment - GPnotebook Education Pharmacological Management of Glycaemia in People with Type 2 Diabetes and Renal Impairment - GPnotebook Education](https://gpnotebookeducation.com/wp-content/uploads/2020/11/GPn-Shortcuts-Renal-Diabetes_FINAL-pdf.jpg)
Pharmacological Management of Glycaemia in People with Type 2 Diabetes and Renal Impairment - GPnotebook Education
![Clinical perspective—evolving evidence of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes - ScienceDirect Clinical perspective—evolving evidence of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S215717162100068X-fx1.jpg)
Clinical perspective—evolving evidence of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes - ScienceDirect
![Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial - The Lancet Diabetes & Endocrinology Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/10ec75a2-ac8b-4508-ba34-7f51f0e7e64f/gr1_lrg.jpg)
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial - The Lancet Diabetes & Endocrinology
![Prevalence and Risk Factors of Chronic Kidney Disease among Type 2 Diabetes Patients: A Cross-Sectional Study in Primary Care Practice | Scientific Reports Prevalence and Risk Factors of Chronic Kidney Disease among Type 2 Diabetes Patients: A Cross-Sectional Study in Primary Care Practice | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-63443-4/MediaObjects/41598_2020_63443_Fig1_HTML.png)
Prevalence and Risk Factors of Chronic Kidney Disease among Type 2 Diabetes Patients: A Cross-Sectional Study in Primary Care Practice | Scientific Reports
Kidney Disease Forum - #T2D (Type 2 diabetes) is one of the main causes of CKD. For those at risk, speak to a doctor about kidney function screening as part of a
![CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease | Nature Reviews Nephrology CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease | Nature Reviews Nephrology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41581-018-0001-y/MediaObjects/41581_2018_1_Fig2_HTML.jpg)
CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease | Nature Reviews Nephrology
AstraZeneca US Community Connections - This #KidneyMonth, know your risk for chronic kidney disease. Type 2 diabetes is a leading risk factor for kidney disease – if you have diabetes, get your
![Folgen einer chronischen Nierenerkrankung bei Typ-2-Diabetes | Offizielle Seite für medizinisches Fachpersonal Folgen einer chronischen Nierenerkrankung bei Typ-2-Diabetes | Offizielle Seite für medizinisches Fachpersonal](https://www.ckd-info.de/sites/g/files/vrxlpx41516/files/2021-02/40-percent-T2D-develop-CKD-medium.png)
Folgen einer chronischen Nierenerkrankung bei Typ-2-Diabetes | Offizielle Seite für medizinisches Fachpersonal
![Outcome trends in people with heart failure, type 2 diabetes mellitus and chronic kidney disease in the UK over twenty years - eClinicalMedicine Outcome trends in people with heart failure, type 2 diabetes mellitus and chronic kidney disease in the UK over twenty years - eClinicalMedicine](https://www.thelancet.com/cms/attachment/dd20b373-fadd-4794-95bc-4e4f445b317c/gr1_lrg.jpg)
Outcome trends in people with heart failure, type 2 diabetes mellitus and chronic kidney disease in the UK over twenty years - eClinicalMedicine
![Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy - ScienceDirect Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2468024921014674-fx1.jpg)